PPT-GOLD 2017 :an update for ICS/LABA role in COPD

management RIANA SARI 1 Agenda Definisi PPOK GOLD 2017 Etiologi patobiologi amp Patologi PPOK Diagnosis dan penilaian awal Tatalaksana PPOK GOLD 2017 Peranan kombinasi. Christopher Worsnop. Department of Respiratory and Sleep . Medicine. Austin Hospital. Melbourne, Australia. COPD DEFINITION. Progressive . airflow . obstruction . that is not fully reversible. .. Most COPD is due to cigarette smoking. for COPD. . ?. GPM-SV-0004-ID . Suradi, . Santi. . Bagian Pulmonologi dan Kedokteran Respirasi . FKUNS / RSUD Dr. Moewardi . Surakarta. . . Central . nervous . system. Vagus nerve. Airway epithelium. GOLD 2017. Resumo. das . principais. . atualizações. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for Diagnosis, Management, and Prevention of COPD (2017). . Disponível. BRONCODILATORA DUAL. Dr. Mark Cohen . Todd. Neumólogo-Intensivista. BRONCODILATADORES. Son la piedra angular del . tratamiento. Los . β2-agonistas de acción corta . tienen un . inicio de acción rápido lo que permite su uso como medicación de rescate. Objectives of Treatment. GOLD 2018: Pharmacologic Treatment Recommendations. GOLD 2018: Pharmacologic Treatment Recommendations (. c. ont). GOLD 2018: Pharmacologic Treatment Recommendations in Groups C and D. Clinical Trial Evidence. Introduction . Therapeutic Recommendations . Therapeutic Recommendations in Groups B and D . Bronchodilators in Stable COPD. ICS in Stable COPD. COPD . Potential AEs of ICS Treatment. 1. NTM-LD and COPD. NP-EU6-00051. The slide . repository . was developed . by . a multidisciplinary. . European scientific committee:. Stefano . Aliberti. , . Respiratory Physician . . University . according to GOLD 2006 and 2011 revisions. . Ivan Vyshnyvetskyy. 1. , Yuriy Mostov. o. y. 2. , Olexiy Onyshchenko. 1. 1 – . Department of. Internal Medicine and General Practice - Family Medicine, Donetsk National Medical University, Donetsk, Ukraine,. in the Treatment of . Asthma and COPD. Margaret Miklich, . PharmD. , BCACP. Clinical Assistant Professor. 1. m. argaret.miklich@temple.edu. I have no conflicts of interest to disclose.. 2. Pharmacist Objectives. in the Treatment of . Asthma and COPD. Margaret Miklich, . PharmD. , BCACP. Clinical Assistant Professor. 1. m. argaret.miklich@temple.edu. I have no conflicts of interest to disclose.. 2. Pharmacist Objectives. bronchodilators include Combiventum Take with Respimatium Take with nebulizer These medications are long-acting Long-acting bronchodilators are used regularly to open the airways and keep them open Lo Summary of key changes . Respiratory Franchise. ZINC code: . GLRESP/COPD/0233 . Date of preparation: December 2016. GOLD 2017 includes major revisions in key areas. Key areas of major revision:. Definition of COPD. *Based on GOLD Risk Stratification 2019. Category. Symptoms. Risk. Suggested Treatment. Co-. Management. ALL Patients. Short-acting Bronchodilator. (rescue). Self-Management. Education. Smoking cessation. Surgical therapy for COPD •L u n g V o l u m e R educt i o n Su r ge r y ( LVR S) oueeductoSugey(S) ResectionImprovescompliance,symptoms,outcomes transplantation lflhlf – Rep l acement f b o